Therapeutic Innovation Award
The Therapeutic Innovation award supports innovative research exploring novel approaches for targeting “undruggable” proteins that play critical roles in cancer, thus laying the foundation for future drug discovery efforts.
Our 2018 Therapeutic Innovation Award, issued in partnership with the Chordoma Foundation, targets the transcription factor brachyury. Brachyury is a key driver of chordoma, a rare tumor of the skull base and spine. Applications for this award are currently closed; the awardee will be announced in the fall of 2018.